Pathology Science Medical Group Inc entered the industry of Health Services in 2012 and has grown to employ 1 to 4 people, generating an annual revenue of $100.000 to $499.999. The NAICS classifies this business under the code 621999, which describes it as a Health Services. For further clarification, the SIC classifies this business under the code 8099 and described it as a Health Services. The business provides service to the B2C market.
To acquire more information, please contact Moises R Zepeda by calling (626) 570-5752 during business hours. You can also write to the business’ Single Location at 5240 East Beverly Boulevard, Los Angeles, California CA 90022. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .
| Company: | Pathology Science Medical Group Inc |
| Representative: | Moises R Zepeda |
| Place of Business: | 5240 East Beverly Boulevard, Los Angeles, CA 90022 |
| Contact Number: | (626) 570-5752 |
| Type of Service: | Health Services |
| SIC Number: | 8099 |
| NAICS Number: | 621999 |
| Locality: | Single Location |
| Market Type: | B2C (Business to Consumer) |
| Began: | 2012 |
| Income/Year: | $100.000 to $499.999 |
| Laborers: | 1 to 4 |
| Share This Company: |
Pathology Science Medical Group Inc is a company operating from Los Angeles, California providing professional Health Services and relevant B2C variables. It was founded in 2012 and registered with the SIC code 8099 as Health Services, and with the NAICS code 621999 as Health Services.
With a current employee count of 1 to 4, Pathology Science Medical Group Inc has gone to report making $100.000 to $499.999 per annum on its journey towards growth. This company invites you to contact its representative Moises R Zepeda at (626) 570-5752 for related queries, or to locate its Single Location using the coordinates 34.031253,-118.152512.
The Single Location can also be found at the street address 5240 East Beverly Boulevard in Los Angeles, California 90022 and can be engaged online through the company website at , the company Twitter , and Facebook page .